199 related articles for article (PubMed ID: 12125986)
1. An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis.
Jaeckle KA; Batchelor T; O'Day SJ; Phuphanich S; New P; Lesser G; Cohn A; Gilbert M; Aiken R; Heros D; Rogers L; Wong E; Fulton D; Gutheil JC; Baidas S; Kennedy JM; Mason W; Moots P; Russell C; Swinnen LJ; Howell SB
J Neurooncol; 2002 May; 57(3):231-9. PubMed ID: 12125986
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
Glantz MJ; Jaeckle KA; Chamberlain MC; Phuphanich S; Recht L; Swinnen LJ; Maria B; LaFollette S; Schumann GB; Cole BF; Howell SB
Clin Cancer Res; 1999 Nov; 5(11):3394-402. PubMed ID: 10589750
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine.
Jaeckle KA; Phuphanich S; Bent MJ; Aiken R; Batchelor T; Campbell T; Fulton D; Gilbert M; Heros D; Rogers L; O'Day SJ; Akerley W; Allen J; Baidas S; Gertler SZ; Greenberg HS; LaFollette S; Lesser G; Mason W; Recht L; Wong E; Chamberlain MC; Cohn A; Glantz MJ; Gutheil JC; Maria B; Moots P; New P; Russell C; Shapiro W; Swinnen L; Howell SB
Br J Cancer; 2001 Jan; 84(2):157-63. PubMed ID: 11161370
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis.
Glantz MJ; LaFollette S; Jaeckle KA; Shapiro W; Swinnen L; Rozental JR; Phuphanich S; Rogers LR; Gutheil JC; Batchelor T; Lyter D; Chamberlain M; Maria BL; Schiffer C; Bashir R; Thomas D; Cowens W; Howell SB
J Clin Oncol; 1999 Oct; 17(10):3110-6. PubMed ID: 10506606
[TBL] [Abstract][Full Text] [Related]
5. A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study.
Phuphanich S; Maria B; Braeckman R; Chamberlain M
J Neurooncol; 2007 Jan; 81(2):201-8. PubMed ID: 16941075
[TBL] [Abstract][Full Text] [Related]
6. Quality-of-life-adjusted survival comparison of sustained-release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis.
Cole BF; Glantz MJ; Jaeckle KA; Chamberlain MC; Mackowiak JI
Cancer; 2003 Jun; 97(12):3053-60. PubMed ID: 12784341
[TBL] [Abstract][Full Text] [Related]
7. Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series.
Chamberlain MC
J Neurooncol; 2012 Aug; 109(1):143-8. PubMed ID: 22539243
[TBL] [Abstract][Full Text] [Related]
8. Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis.
Bomgaars L; Geyer JR; Franklin J; Dahl G; Park J; Winick NJ; Klenke R; Berg SL; Blaney SM
J Clin Oncol; 2004 Oct; 22(19):3916-21. PubMed ID: 15459213
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacology of encapsulated sustained-release cytarabine.
Murry DJ; Blaney SM
Ann Pharmacother; 2000 Oct; 34(10):1173-8. PubMed ID: 11054987
[TBL] [Abstract][Full Text] [Related]
10. Current treatment approaches for neoplastic meningitis: nursing management of patients receiving intrathecal DepoCyt.
Craig C
Oncol Nurs Forum; 2000 Sep; 27(8):1225-30; quiz 1231-2. PubMed ID: 11013903
[TBL] [Abstract][Full Text] [Related]
11. Liposomal cytarabine (DepoCyte) for the treatment of neoplastic meningitis.
Rueda Domínguez A; Olmos Hidalgo D; Viciana Garrido R; Torres Sánchez E
Clin Transl Oncol; 2005 Jul; 7(6):232-8. PubMed ID: 16131445
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of drugs formulated with DepoFoam: a sustained release drug delivery system for parenteral administration using multivesicular liposome technology.
Angst MS; Drover DR
Clin Pharmacokinet; 2006; 45(12):1153-76. PubMed ID: 17112293
[TBL] [Abstract][Full Text] [Related]
13. Liposomal cytarabine in neoplastic meningitis from primary brain tumors: a single institutional experience.
Gaviani P; Corsini E; Salmaggi A; Lamperti E; Botturi A; Erbetta A; Milanesi I; Legnani F; Pollo B; Silvani A
Neurol Sci; 2013 Dec; 34(12):2151-7. PubMed ID: 23525755
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal Fluid Drug Concentrations and Clinical Outcome of Patients with Neoplastic Meningitis Treated with Liposomal Cytarabine.
Bohn JP; Reinstadler V; Pall G; Stockhammer G; Steurer M; Oberacher H; Wolf D
Eur J Drug Metab Pharmacokinet; 2019 Dec; 44(6):845-851. PubMed ID: 31435852
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
Niwińska A; Rudnicka H; Murawska M
Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
[TBL] [Abstract][Full Text] [Related]
16. [Cerebrospinal fluid examination after liposomal cytarabine intrathecal injection].
Guillaume C; Vegas H; Pastuszka A; Le Brun C; Lanotte P
Ann Biol Clin (Paris); 2018 Oct; 76(5):568-570. PubMed ID: 30154068
[TBL] [Abstract][Full Text] [Related]
17. [Phase I study of intrathecal chemotherapy with NS-101 for leptomeningeal carcinomatosis in Japan].
Nakagawa H; Tamura M; Fukushima Y; Majima S; Yamada K
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1799-805. PubMed ID: 18030013
[TBL] [Abstract][Full Text] [Related]
18. Feasibility and toxicity of intrathecal liposomal cytarabine in 5 children and young adults with refractory neoplastic meningitis.
Benesch M; Sovinz P; Krammer B; Lackner H; Mann G; Schwinger W; Gadner H; Urban C
J Pediatr Hematol Oncol; 2007 Apr; 29(4):222-6. PubMed ID: 17414563
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and safety of intrathecal liposomal cytarabine in children aged <3 years.
Peyrl A; Sauermann R; Traunmueller F; Azizi AA; Gruber-Olipitz M; Gupper A; Slavc I
Clin Pharmacokinet; 2009; 48(4):265-71. PubMed ID: 19492871
[TBL] [Abstract][Full Text] [Related]
20. Clinical improvement and survival in breast cancer leptomeningeal metastasis correlate with the cytologic response to intrathecal chemotherapy.
Clatot F; Philippin-Lauridant G; Ouvrier MJ; Nakry T; Laberge-Le-Couteulx S; Guillemet C; Veyret C; Blot E
J Neurooncol; 2009 Dec; 95(3):421-426. PubMed ID: 19557501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
